We are happy to announce that the French Government has renewed our accreditation for Crédit d’Impôt Recherche (CIR) for five additional years (2023, 2024, 2025, 2026, 2027).
GalChimia provides R&D services covering the whole range of specialties needed in the development of new drugs, from synthetic chemistry to analytical and process chemistry. GalChimia has become a European referent in organic synthesis as a result of our commitment with innovation: the development of new synthetic methodologies, the investment in new technologies, and continuous training for our team.
Decision letter for Crédit d’Impôt Recherche accreditation
